At a Glance
| Citicoline | 5-Hydroxytryptophan | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 250–1000 mg | 100–300 mg |
| Total Duration | 5.5–8.5 hrs | — |
| Routes | oral | oral |
| Effects | 15 documented | 9 documented |
Citicoline, a Nootropic, and 5-Hydroxytryptophan, a Nootropic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Nootropics, meaning they share a common pharmacological foundation. They share 2 documented effects in common, with 13 effects unique to Citicoline and 7 unique to 5-Hydroxytryptophan. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Citicoline | 5-Hydroxytryptophan | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 250–1000 mg | 100–300 mg |
| Total Duration | 5.5–8.5 hrs | — |
| Routes | oral | oral |
| Effects | 15 documented | 9 documented |
| Level | Citicoline | 5-Hydroxytryptophan |
|---|---|---|
| Threshold | 50 mg | 25 mg |
| Light | 100–250 mg | 50–100 mg |
| Common | 250–1000 mg | 100–300 mg |
| Strong | 1000–2000 mg | 300–500 mg |
| Heavy | 2000 mg | 500 mg |
Citicoline
5-Hydroxytryptophan
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.